Fig. 5From: Quinazolin-4-one derivatives lacking toxicity-producing attributes as glucokinase activators: design, synthesis, molecular docking, and in-silico ADMET prediction3D docking poses displaying interaction of (a) RO-28-1675 and (b) piragliatin in the binding site of protein 1V4SBack to article page